Langerhans cell sarcoma arising from chronic lymphocytic lymphoma/small lymphocytic leukemia: Lineage analysis and BRAF V600E mutation study

North American Journal of Medical Sciences

Volumn 5, Issue 6, 2013, Pages 386-391

  Chen, Weiwei ^a   Jaffe, Ronald ^b   Zhang, Linsheng ^c   Hill, Charlie ^c   Block, Anne Marie ^d   Sait, Sheila ^d   Song, Buer ^a   Liu, Yunguang ^a   Cai, Donghong ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

BRAF V600E mutation; Clonality; Langerhans cell sarcoma; Transdifferentiation

Indexed keywords

B RAF KINASE; CARBOPLATIN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; PROTEIN S 100; T6 ANTIGEN;

ABDOMINAL PRESSURE; AGED; ANOREXIA; ARTICLE; CASE REPORT; DYSPNEA; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LANGERHANS CELL SARCOMA; LYMPHATIC LEUKEMIA; LYMPHOCYTOMA; MALAISE; POINT MUTATION; POLYMERASE CHAIN REACTION; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY;

EID: 84879520389     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.114172     Document Type: Article

References (24)

1. Wang E, Hutchinson CB, Huang Q, Sebastian S, Rehder C, Kanaly A, et al. Histiocytic sarcoma arising in indolent small b-cell lymphoma: Report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolution. Leuk Lymphoma 2010;51:802-12.
2. Zhang D, McGuirk J, Ganguly S, Persons DL. Histiocytic/ dendritic cell sarcoma arising from follicular lymphoma involving the bone: A case report and review of literature. Int J Hematol 2009;89:529-32.
3. Baer MR, Krantz SB, Cousar JB, Glick AD, Collins RD. Malignant histiocytoses developing in patients with b-cell lymphomas. Report of two cases. Cancer 1986;57:2175-84.
4. Vasef MA, Zaatari GS, Chan WC, Sun NC, Weiss LM, Brynes RK. Dendritic cell tumors associated with low-grade b-cell malignancies. Report of three cases. Am J Clin Pathol 1995;104:696-701.
5. Wetzler M, Kurzrock R, Goodacre AM, McLaughlin P, Ku S, Talpaz M. Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type. Cancer 1995;76:609-17.
6. Cossu A, Deiana A, Lissia A, Dedola MF, Cocco L, Palmieri G, et al. Synchronous interdigitating dendritic cell sarcoma and b-cell small lymphocytic lymphoma in a lymph node. Arch Pathol Lab Med 2006;130:544-7.
7. Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR, et al. Transformation of chronic lymphocytic leukemia/ small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: Evidence for transdifferentiation of the lymphoma clone. Am J Clin Pathol 2009;132:928-39.
8. Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: Evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111:5433-9.
9. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of seven cases. Mod Pathol 2011;24:1421-32.
10. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent braf mutations in langerhans cell histiocytosis. Blood 2010;116:1919-23.
11. Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, et al. Brafv600e mutant protein is expressed in cells of variable maturation in langerhans cell histiocytosis. Blood 2012;120:e28-34.
12. Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, et al. Immunohistochemistry is highly sensitive and specific for the detection of v600e braf mutation in melanoma. Am J Surg Pathol 2013;37:61-5.
13. Bosmuller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, et al. Detection of the braf v600e mutation in serous ovarian tumors: A comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific pcr. Hum Pathol 2013;44:329-35.
14. Wang E, Papalas J, Hutchinson CB, Kulbacki E, Huang Q, Sebastian S, et al. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: A divergent (bilineal) neoplastic transformation of an indolent b-cell lymphoma in a single individual. Am J Surg Pathol 2011;35:457-463.
15. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of b cells into macrophages. Cell 2004;117:663-76.
16. Cobaleda C, Jochum W, Busslinger M. Conversion of mature b cells into t cells by dedifferentiation to uncommitted progenitors. Nature 2007;449:473-7.
17. Carotta S, Nutt SL. Losing b cell identity. Bioessays 2008;30:203-7.
18. Ratei R, Hummel M, Anagnostopoulos I, Jahne D, Arnold R, Dorken B, et al. Common clonal origin of an acute b-lymphoblastic leukemia and a langerhans' cell sarcoma: Evidence for hematopoietic plasticity. Haematologica 2010;95:1461-6.
19. Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab 2009;296:E367-77.
20. Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL, et al. Cytogenetic characterisation in chinese patients with chronic lymphocytic leukemia: A prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 2008;49:1887-92.
21. Sandberg ML, Sutton SE, Pletcher MT, Wiltshire T, Tarantino LM, Hogenesch JB, et al. C-myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005;8:153-66.
22. Zhang Y, Jin H, Li L, Qin FX, Wen Z. Cmyb regulates hematopoietic stem/progenitor cell mobilization during zebrafish hematopoiesis. Blood 2011;118:4093-101.
23. Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory erdheim-chester disease and langerhans cell histiocytosis harboring the braf v600e mutation. Blood 2013;121:1495-500.
24. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with braf v600e mutation. N Engl J Med 2011;364:2507-16.